Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-08-29
2010-11-02
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S023000, C514S385000, C514S400000, C514S561000
Reexamination Certificate
active
07825084
ABSTRACT:
Provided are compositions comprising beta-alanylhistidine peptides and beta-alanines, and methods for administering these peptides and amino acids. In one aspect, the compositions and methods cause an increase in the blood plasma concentrations of beta-alanine and/or creatine.
REFERENCES:
patent: 3934036 (1976-01-01), Irikura
patent: 4120852 (1978-10-01), Bauer et al.
patent: 4761399 (1988-08-01), Pilotto et al.
patent: 4883861 (1989-11-01), Grill et al.
patent: 5561110 (1996-10-01), Michaelis et al.
patent: 5965596 (1999-10-01), Harris et al.
patent: 5976559 (1999-11-01), De Lacharriere et al.
patent: 6071888 (2000-06-01), Rihova et al.
patent: 6172098 (2001-01-01), Harris et al.
patent: 6426361 (2002-07-01), Harris et al.
patent: 6680294 (2004-01-01), Harris et al.
patent: 7504376 (2009-03-01), Harris et al.
patent: 2009/0220575 (2009-09-01), Harris et al.
patent: 34 24 781 (1985-01-01), None
patent: 0 449 787 (1991-10-01), None
patent: 1210940 (2002-06-01), None
patent: 54-159393 (1979-12-01), None
patent: 61-204120 (1986-09-01), None
patent: 64-042425 (1989-02-01), None
patent: 04-095026 (1992-03-01), None
patent: 04-112825 (1992-04-01), None
patent: 06-024976 (1994-02-01), None
patent: 7-236460 (1995-09-01), None
patent: 7-509230 (1995-10-01), None
patent: 8-224073 (1996-09-01), None
patent: 03-095125 (2000-10-01), None
patent: 2002-51730 (2002-02-01), None
patent: WO 90/06102 (1990-06-01), None
patent: WO 93/04690 (1993-03-01), None
patent: WO 98/06278 (1998-02-01), None
patent: WO 2004/091497 (2004-10-01), None
Office Action, issued Apr. 27, 2010, in connection with Japanese Patent Application No. 2006-509880 dated 2006.
Supplemental European Search Report, issued Apr. 21, 2010 in connection with European Patent Application Serial No. 04749952.0.
Babizhayev et al., “L-carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities,” Biochem J. 304 ( Pt 2):509-516 (1994).
Bergström, J. “Muscle electrolytes in man,” Scand. J. Clin. Invest. 14(Suppl. 68):1-110 (1962).
Brooke, M. and K. Kaiser, “Muscle fiber types: how many and what kind?,” Arch. Neruol. 23:369-379 (1970).
Burd et al., “Carnosine in primary afferents of the olfactory system: an autoradiographic and biochemical study,” J. Neurosci. 2:244-255 (1982).
Collegiate Sport Nutrition,CarnoSyn®—Carnosine Synthesizer[Brochure] (4 pages) (2007).
Derave et al., “Beta-Alanine supplementation augments muscle carnosine content and attenuates fatigue during repeated isokinetic contraction bouts in trained sprinters,” J. Appl. Physiol. 103:1736-1743 (2007).
Derave et al., “Beta-alanine supplementation augments muscle carnosine content and attenuates fatigue in trained sprinters,” National Strength and Conditioning Association Annual Conference, Atlanta, Jul. 2007.
Di Pasquale, M., “Conditionally essential amino acids,” pp. 127-145 in Amino Acids and Proteins for the Athlete, CRC Press:Boca Raton (1997).
Dunnett et al., “Carnosine, anserine and taurine contents in individual fibres from the middle gluteal muscle of the camel,” Res. Vet. Sci., 62:213-216 (1997).
Dunnett et al., “Influence of oral beta-alanine and L-histidine supplementation on the carnosine content of the gluteus medius,” Equine Vet. J. Suppl. 30:499-504 (1999).
Dunnett et al., “Plasma carnosine concentration: diurnal variation and effects of age, exercise and muscle damage,” Equine Vet. J. Suppl. 34:283-287 (2002).
Dunnett, M. and R. Harris, “Determination of carnosine and other biogenic imidazoles in equine plasma by isocratic reversed-phase ion-pair high-performance liquid chromatography,” J. Chromatogr. 579:45-53 (1992).
Dunnett, M. and R. Harris, “High-performance liquid chromatographic determination of imidazole dipeptides, histidine, 1-methylhistidine and 3-methylhistidine in muscle and individual muscle fibers,” J. Chromatogr. B. Biomed. Appl., 688:47-55 (1997).
Dunnett, M., “Carnosine metabolism and function in the thoroughbread horse (anaerobic exercise),” Dissertation(Open University) vol. 57/04-C of dissertation abstracts 1143 (1996).
Dunnett, M., “High performance liquid-chromatographic determination of N-alpha-acetyl-L-carnosine in equine plasma,” J. Chromatogr. B. Biomed. Sci. Appl. 688:150-154 (1997).
Harris et al., “The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis,” Amino Acids 30:279-289 (2006).
Harris et al., “Absorption of creatine supplied as a drink, in meat or in solid form,” J Sports Science 20:147-151 (2002).
Harris et al., “Beta-alanine Supplementation for 10 weeks significantly increased muscle carnosine levels,” IUPS 2005 Meeting Abstract 566.8 from p. A969, Experimental Biology, San Diego, Apr. 2005.
Harris et al., “Changes in plasma β-alanine concentration following administration of free or peptide bound forms,” Experimental Biology Conference, San Diego, Apr. 2003.
Harris et al., “Effect of 14 and 28 days β-alanine (Carnosyn™) supplementation on isometric endurance of the knee extensors,” 3rd Annual International Society of Sports Nutrition Conference, Las Vegas, Jun. 2006.
Harris et al., “Effect of Combined β-alanine and creatine monohydrate supplementation on exercise performance,” Medicine & Science in Sports & Exercise, Journal of the American College of Sports Medicine Conference, San Francisco, 35(5) Supplement 1:s218, May 2003.
Harris et al., “Effects of 14 days of beta-alanine supplementation on isometric endurance of the knee extensors,” Medicine and Science in Sports and Exercise 38(5) Supplement, pp. S125-S126, Jun. 2006.
Harris et al., “Elevation of carnosine in muscle of normal subjects by supplementation with β-alanine in free or peptide bound form,” Experimental Biology Conference, San Diego, Apr. 2003.
Harris et al., “Muscle buffering capacity and dipeptide content in the thoroughbread horse, greyhound dog and man,” Comp. Biochem. Physiol. 97A(2):249-251 (1990).
Harris et al., “The carnosine content of V lateralis in vegetarians and omnivores,” FASEB Journal 21(6):A943, Experimental Biology, Washington D.C., Apr. 2007.
Harris et al., “The distribution of carnosine and taurine in different muscle fibre types from human v lateralis and the effects of beta-alanine supplementation,” 9th International Congress on Amino Acids & Proteins, Vienna, Aug. 2005.
Harris et al., “The distribution of carnosine in different muscle fibre types with beta-alanine supplementation,” IUPS 2005 Meeting Abstract 665.36 from p. A1125, Experimental Biology, San Diego, Apr. 2005.
Harris et al., “The effect of a β-alanine supplement on the muscle carnosine content during training,” Experimental Biology, San Francisco, Abstract 483.35, Apr. 2006.
Harris et al., “The effect of a supplement containing β-alanine on muscle carnosine synthesis and exercise capacity, during 12 wk combined endurance and weight training,” 3rd Annual International Society of Sports Nutrition Conference, Las Vegas, Jun. 2006.
Harris et al., “The effect of physical training on the carnosine content of V lateralis using a one-leg training model,” Medicine and Science in Sports and Exercise 39(5) Supplement, pp. S91, Jun. 2006.
Harris et al., “The effect of very high interval training on the carnosine content and buffering capacity of V lateralis from humans,” Experimental Biology, Washington D.C., Apr. 2007.
Harris et al., “The effect of whole body physical training on the carnosine content of V lateralis,” Experimental Biology, Washington D.C., Apr. 2007.
Harris et al., “The influence of B-alan
Dunnett Mark
Harris Roger
Henley, III Raymond J
K & L Gates LLP
Miskiel Frank J.
Natural Alternatives International, Inc.
Seidman Stephanie
LandOfFree
Methods and compositions for increasing the anaerobic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for increasing the anaerobic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for increasing the anaerobic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4251155